Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Algernon Pharmaceuticals (AGNPF)
OTHER OTC:AGNPF
Holding AGNPF?
Track your performance easily
AGNPF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.04 - $0.12
Previous Close$0.07
Volume3.54K
Average Volume (3M)10.34K
Market Cap
$1.29M
Enterprise Value$1.40M
Total Cash (Recent Filing)C$76.28K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.67
Next Earnings
Dec 20, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding21,940,779
10 Day Avg. Volume3,669
30 Day Avg. Volume10,342
Standard Deviation0.28
R-Squared0.00641
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)3.40
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Algernon Pharmaceuticals News
PremiumCompany Announcements
Algernon Pharmaceuticals Secures Funding Through Private Placement
PremiumCompany Announcements
Algernon Pharmaceuticals Boosts Private Placement
PremiumCompany Announcements
Algernon Pharmaceuticals Launches Private Placement
PremiumCompany Announcements
Algernon Pharmaceuticals Completes Key Funding Round
Options Prices
Currently, No data available
---
Ownership Overview
50.12% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
49.88% Public Companies and
Individual Investors
AGNPF FAQ
What was Algernon Pharmaceuticals’s price range in the past 12 months?
Algernon Pharmaceuticals lowest stock price was $0.04 and its highest was $0.12 in the past 12 months.
What is Algernon Pharmaceuticals’s market cap?
Currently, no data Available
When is Algernon Pharmaceuticals’s upcoming earnings report date?
Algernon Pharmaceuticals’s upcoming earnings report date is Dec 20, 2024 which is in 91 days.
How were Algernon Pharmaceuticals’s earnings last quarter?
Algernon Pharmaceuticals released its earnings results on Jul 29, 2024. The company reported $0.049 earnings per share for the quarter, beating the consensus estimate of N/A by $0.049.
Is Algernon Pharmaceuticals overvalued?
According to Wall Street analysts Algernon Pharmaceuticals’s price is currently Overvalued.
Does Algernon Pharmaceuticals pay dividends?
Algernon Pharmaceuticals does not currently pay dividends.
What is Algernon Pharmaceuticals’s EPS estimate?
Algernon Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Algernon Pharmaceuticals have?
Algernon Pharmaceuticals has 21,940,779 shares outstanding.
What happened to Algernon Pharmaceuticals’s price movement after its last earnings report?
Algernon Pharmaceuticals reported an EPS of $0.049 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Algernon Pharmaceuticals?
Currently, no hedge funds are holding shares in AGNPF
---
Algernon Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.38%
12-Months-Change
Fundamentals
Return on Equity
-94.05%
Trailing 12-Months
Asset Growth
-36.73%
Trailing 12-Months
Company Description
Algernon Pharmaceuticals
Algernon Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the development of repurposed therapeutic drugs. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, and idiopathic pulmonary fibrosis. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
---
Technical Analysis
---